Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.

Kumai T, Sakaue S, Ominato H, Inoue T, Sato R, Wakisaka R, Komatsuda H, Hayashi R, Kono M, Yamaki H, Ohara K, Kishibe K, Takahara M

Open source

DOI
10.1158/2767-9764.crc-25-0796
Published
2026 Jul 1
Container
Cancer research communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/2767-9764.crc-25-0796,
  title = {Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.},
  author = {Kumai T and Sakaue S and Ominato H and Inoue T and Sato R and Wakisaka R and Komatsuda H and Hayashi R and Kono M and Yamaki H and Ohara K and Kishibe K and Takahara M},
  year = {2026},
  journal = {Cancer research communications},
  doi = {10.1158/2767-9764.crc-25-0796},
  url = {https://doi.org/10.1158/2767-9764.crc-25-0796}
}

RIS

TY  - JOUR
TI  - Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.
AU  - Kumai T
AU  - Sakaue S
AU  - Ominato H
AU  - Inoue T
AU  - Sato R
AU  - Wakisaka R
AU  - Komatsuda H
AU  - Hayashi R
AU  - Kono M
AU  - Yamaki H
AU  - Ohara K
AU  - Kishibe K
AU  - Takahara M
PY  - 2026
JO  - Cancer research communications
DO  - 10.1158/2767-9764.crc-25-0796
UR  - https://doi.org/10.1158/2767-9764.crc-25-0796
ER  - 

APA

T, K., S, S., H, O., T, I., R, S., R, W., H, K., R, H., M, K., H, Y., K, O., K, K., & M, T. (2026). Peptide-Reactive T-cell Response as a Novel Biomarker in Patients with Head and Neck Cancer Treated with Anti-PD-1 Antibody.. Cancer research communications. https://doi.org/10.1158/2767-9764.crc-25-0796

Source records